F. Pazderka

1.3k total citations
36 papers, 1.1k citations indexed

About

F. Pazderka is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, F. Pazderka has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in F. Pazderka's work include Renal Transplantation Outcomes and Treatments (6 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). F. Pazderka is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). F. Pazderka collaborates with scholars based in Canada, United States and Vietnam. F. Pazderka's co-authors include Philip F. Halloran, B. Michael Longenecker, R. F. Ruth, Thomas D. Batiuk, Kiril Trpkov, Kim Solez, Patricia Campbell, Sandra M. Cockfield, Alan B. Douglass and J. S. Gavora and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

F. Pazderka

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Pazderka Canada 15 390 342 233 220 180 36 1.1k
Matthew F. Cusick United States 15 408 1.0× 226 0.7× 270 1.2× 198 0.9× 189 1.1× 48 1.3k
Caroline M. Lanigan United States 12 644 1.7× 218 0.6× 306 1.3× 220 1.0× 141 0.8× 13 1.3k
Angela Siegling Germany 13 239 0.6× 39 0.1× 133 0.6× 121 0.6× 76 0.4× 21 730
Allison Ac United States 17 288 0.7× 77 0.2× 271 1.2× 226 1.0× 83 0.5× 39 1.0k
Zsolt Csapó Hungary 21 72 0.2× 46 0.1× 263 1.1× 139 0.6× 197 1.1× 74 1.1k
Hiroki Yamada Japan 14 333 0.9× 19 0.1× 1.1k 4.8× 310 1.4× 78 0.4× 44 2.1k
Phyllis‐Jean Linton United States 20 1.3k 3.4× 29 0.1× 274 1.2× 317 1.4× 64 0.4× 28 1.9k
Timothy W. Phares United States 22 576 1.5× 18 0.1× 260 1.1× 288 1.3× 32 0.2× 40 1.4k
Kanchan Rao United Kingdom 28 790 2.0× 44 0.1× 487 2.1× 321 1.5× 134 0.7× 80 2.2k
Ana Marie Landin United States 17 746 1.9× 10 0.0× 293 1.3× 447 2.0× 100 0.6× 32 1.8k

Countries citing papers authored by F. Pazderka

Since Specialization
Citations

This map shows the geographic impact of F. Pazderka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Pazderka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Pazderka more than expected).

Fields of papers citing papers by F. Pazderka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Pazderka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Pazderka. The network helps show where F. Pazderka may publish in the future.

Co-authorship network of co-authors of F. Pazderka

This figure shows the co-authorship network connecting the top 25 collaborators of F. Pazderka. A scholar is included among the top collaborators of F. Pazderka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Pazderka. F. Pazderka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trpkov, Kiril, Patricia Campbell, F. Pazderka, et al.. (1996). PATHOLOGIC FEATURES OF ACUTE RENAL ALLOGRAFT REJECTION ASSOCIATED WITH DONOR-SPECIFIC ANTIBODY. Transplantation. 61(11). 1586–1592. 238 indexed citations
2.
Batiuk, Thomas D., et al.. (1996). CYCLOSPORINE INHIBITION OF LEUKOCYTE CALCINEURIN IS MUCH LESS IN WHOLE BLOOD THAN IN CULTURE MEDIUM. Transplantation. 61(1). 158–161. 39 indexed citations
3.
Pazderka, F., et al.. (1996). The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leucocytes. Transplant Immunology. 4(1). 23–31. 16 indexed citations
4.
Batiuk, Thomas D., et al.. (1995). Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.. Journal of Clinical Investigation. 96(3). 1254–1260. 79 indexed citations
5.
Batiuk, Thomas D., F. Pazderka, & Philip F. Halloran. (1995). CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS. Transplantation. 59(10). 1400–1404. 97 indexed citations
6.
Maksymowych, Walter P., Shasha Tao, María E. Suarez‐Almazor, et al.. (1995). Polymorphism in the LMP2 and LMP7 genes and adult rheumatoid arthritis: no relationship with disease susceptibility or outcome. Tissue Antigens. 46(2). 136–139. 12 indexed citations
7.
Madrenas, Joaquı́n, F. Pazderka, Nollaig A. Parfrey, & Philip F. Halloran. (1992). Thymus-independent expression of a truncated T cell receptor-alpha mRNA in murine kidney. The Journal of Immunology. 148(2). 612–619. 7 indexed citations
8.
Douglass, Alan B., Peter L. Hays, F. Pazderka, & J. M. Russell. (1991). Florid Refractory Schizophrenias That Turn Out to Be Treatable Variants of HLA-Associated Narcolepsy. The Journal of Nervous and Mental Disease. 179(1). 12–17. 64 indexed citations
9.
Pazderka, F., et al.. (1991). The use of polymerase chain reaction (PCR) for assessing interferon-gamma (INF-gamma) mRNA levels in human lymphocytes.. PubMed. 23(1 Pt 1). 241–2. 2 indexed citations
10.
Morgan, Kenneth, T. Holmes, F. Pazderka, & John B. Dossetor. (1986). Segregation of HLA A,B haplotypes and the distribution of antigen mismatches between mother and offspring in Hutterite families.. PubMed. 38(6). 971–7. 5 indexed citations
11.
Pazderka, F., et al.. (1983). Induction of suppressor cells in autologous mixed lymphocyte culture (AMLC) in humans. Cellular Immunology. 75(1). 122–133. 14 indexed citations
12.
Marchuk, Linda L., et al.. (1982). Beneficial effect of blood transfusion in HLA identical and haploidentical renal allografts.. PubMed. 14(4). 690–2. 1 indexed citations
13.
Pazderka, F., et al.. (1982). A search for monocyte-specific antibodies in the study of monocyte antigen systems in the human. Human Immunology. 5(2). 169–170. 2 indexed citations
14.
Pazderka, F., et al.. (1981). Donor-specific suppressor cells in renal allograft recipients: technical aspects and clinical studies.. PubMed. 13(3). 1645–8. 3 indexed citations
15.
Pazderka, F., et al.. (1979). Donor-specific monitoring of transplant patients.. PubMed. 11(2). 1235–6. 2 indexed citations
16.
Johny, Molly, et al.. (1979). Monocyte-specific antigens--detection by the antibody-dependent cellular cytotoxicity (ADCC) method.. PubMed. 11(4). 1970–3. 2 indexed citations
17.
Vitetta, E S, J W Uhr, J Klein, et al.. (1977). Homology of (murine) H–2 and (human) HLA with a chicken histocompatibility antigen. Nature. 270(5637). 535–536. 32 indexed citations
18.
Longenecker, B. Michael, J Menezes, E. J. Sanders, F. Pazderka, & R. F. Ruth. (1977). A New Class of Infectious Agents Detectable by the Production of Chorioallantoic Membrane Lesions by Human Lymphoblastoid Cell Lines and Their Culture Supernatants 2. JNCI Journal of the National Cancer Institute. 58(4). 853–862. 4 indexed citations
19.
Longenecker, B. Michael, et al.. (1977). A T-cell antigen system of chickens: Ly-4 and Marek's disease. Immunogenetics. 5(1). 535–552. 36 indexed citations
20.
Longenecker, B. Michael, F. Pazderka, Haley Stone, J. S. Gavora, & R. F. Ruth. (1975). In ovo assay for Marek's disease virus and turkey herpesvirus. Infection and Immunity. 11(5). 922–931. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026